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Background: Although epidemiologic and socioeconomic criteria and biomedical risk factors indicate high-priority
for tuberculosis (TB) control in Mexico, molecular epidemiology studies of the disease in the country are scarce.
Methods: Complete sociodemographic and clinical data were obtained from 248 of the 432 pulmonary TB (PTB)
cases confirmed from 2006 to 2010 on the population under epidemiological surveillance in the state of San Luis
Potosí, México. From most PTB cases with complete data Mycobacterium tuberculosis complex (MTC) isolates were
recovered and their spoligotypes, lineages and families, geographic distribution and drug resistance determined.
Results: Pulmonary tuberculosis incidence ranged from 2.4 to 33.4 (cases per 100,000 inhabitants) in the six state
sanitary jurisdictions that were grouped in regions of low (jurisdictions I-II-III), intermediate (jurisdictions IV-V) and
high incidence (jurisdiction VI) with 6.2, 17.3 and 33.4 rates, respectively. Most patients were poor, 50-years-median-
age males and housewives. Among the 237 MTC spoligotyped isolates, 232 corresponded to M. tuberculosis (104
spoligotypes in 24 clusters) and five to M. bovis. The predominant Euro-American lineage was distributed all over
the state, the East-Asian lineage (Beijing family) in the capital city, the Indo-Oceanic (Manila family) in eastern
localities, and M. bovis in rural localities.
Conclusions: In San Luis Potosí TB affects mainly poor male adults and is caused by M. tuberculosis and to a minor
extent by M. bovis. There is great genotypic diversity among M. tuberculosis strains, the Euro-American lineage
being much more prevalent than the Indo-Oceanic and East-Asian lineages. The frequency of resistant strains is
relatively low and not associated to any particular lineage.
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In 2007 the global incidence of tuberculosis (TB) was
139 (cases per 100,000 inhabitants), whereas in the
Americas it was 36.8 [1], and in Mexico 13.5 [2]. In the
same year the Mexican states with highest incidences
were Baja California (35.3) and Tamaulipas (32.7)
whereas the incidence was 12.2 in the state of San Luis
Potosí [2], where this study was performed. Although
the national TB incidence is relatively low, the weight of
epidemiologic and socioeconomic criteria and biomedical* Correspondence: rlopez@ipicyt.edu.mx
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distribution, and reproduction in any mediumrisk factors define Mexico as a high-priority country for
TB control in the Americas [3].
TB reemergence, its association with the HIV-AIDS
and diabetes epidemics [4,5] and the emergence and
spread of MDR strains demand that epidemiological and
genotyping data of Mycobacterium tuberculosis Complex
(MTC) isolates be used to identify chains of transmission
[6] and to differentiate TB cases due to endogenous
reactivation [7].
Spoligotyping, based on the polymorphism of spacer
sequences of the direct repeat region (DR) is used to dif-
ferentiate MTC isolates [8]. Although less discriminatory
than IS6110-based RFLP typing, it is a fast and cost-
effective method allowing simultaneous analysis of nu-
merous samples and generates contextual informationentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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ligotyping also identifies M. bovis strains, which usually
carry few IS6110 copies [10].
The Euro-American lineage of M. tuberculosis pre-
dominates in Mexico [11], where some areas also have
high frequencies of the Indo-Oceanic lineage [12]. In
Mexico M. bovis also appears to be a relevant cause of
pulmonary TB (PTB) in humans [13,14], and the Beijing
family of the M. tuberculosis East-Asian lineage has been
mentioned in a recent paper [5].
In this work we analyze the epidemiology, geographic
distribution, lineages, families and drug resistance patterns
of the MTC strains isolated from PTB cases in the state of
San Luis Potosí, Mexico.
Methods
Territory and population
The state of San Luis Potosí, located in North-Central
Mexico, is divided in 58 municipalities and six sanitary
districts designated as jurisdictions I, II, III, IV, V and VI
(Table 1). From January 2006 to March 2010, 1339 PTB
cases were confirmed in the population submitted to
passive epidemiologic surveillance (patients 15-years-old
or older with productive cough for more than two weeks
and positive acid-fast bacilli smear) and included in a
DOT program whose scheme and drugs were provided
and supervised by the State Tuberculosis Program, as
defined by the Mexican Standard for Tuberculosis Preven-
tion and Control [15]. Clinical information was elicited by
medical personnel of dedicated brigades of the State TB
Program and recorded in the National Epidemiologic
Surveillance Platform. PTB incidence rates calculated
from these cases were normalized for the population
projected for 2010 [16] and complete sociodemographic
and clinical data (name, sex, age, place of residence, oc-
cupation, formal education, previous TB history, contact
with TB cases, concomitant disease and acid-fast bacilli
smear) were collected from 248 cases (Figure 1).Table 1 Population density, PTB incidence and MTC isolates p
Sanitary jurisdiction
Name Municipalities Area (km2) Inhabitants Inhabita
I 2 1,724.1 1,054,522 611
II 11 21,757.9 216,348 9.
III 13 13,447.0 273,705 20
IV 12 12,410.1 239,800 19
V 9 8,900.0 372,945 41
VI 11 2,306.8 338,193 146
Total 58 60,545.9 2,495,513 41
*MTC, Mycobacterium tuberculosis complex.
†PTB cases confirmed by positive acid-fast bacilli smear.
‡PTB cases per 100,000 inhabitants.
§MTC cultures recovered and analyzed by spoligotyping.Alcoholism was defined as a behavior disorder indicated
by a rank > 8 in the Alcohol Use Disorders Identification
Test (AUDIT) [17], and malnutrition by a body mass
index < 18.5 [18]. Diabetes mellitus was defined by blood
glucose levels > 126 mg/dl in fasting samples or > 200 mg/dl
in random samples [19].
As indicator of socioeconomic level, the marginalization
degree —a continuous integrative measure of the fraction
of the population lacking access to goods and services
essential for the development of basic capabilities— was
stratified into five discrete indexes: very high, high,
medium, low and very low [20]. The Ethics and Research
Committee of the San Luis Potosí State Health Services
approved the study.
Culture and drug susceptibility of the MTC isolates
Sputum specimens were decontaminated with the Petroff
method and simultaneously inoculated in the VersaTREK
Myco System (TREK Diagnostic Systems, Cleveland, OH)
and Lowenstein-Jensen medium. Positive cultures were
identified as MTC members with the Cobas Amplicor M.
tuberculosis test (Roche Diagnostics, Grenzach-Whylen,
Germany). MTC isolates were cryopreserved at −70°C in
Middlebrook 7H9 medium (TREK Diagnostic Systems,
Cleveland, OH), recovered by reinoculation in the same
medium and propagated in Lowenstein-Jensen medium
from which colonies were picked and DNA extracted for
genotyping.
Drug susceptibility was determined with the MYCO
TB Susceptibility Testing kit (TREK Diagnostic Systems,
Cleveland, OH), in which a standard dilution of each
isolate was inoculated in Middlebrook 7H9 medium
containing the drugs assayed at two concentrations:
streptomycin 2 and 6 μg/ml; isoniazid 0.1 and 0.4 μg/ml;
rifampicin 5 and 1 μg/ml; ethambutol 5 and 8 μg/ml.
Each test was controlled with the M. tuberculosis H37Rv
sensitive strain and the ATCC 35820, 35822, 35837 and
35838 strains as controls for streptomycin-, isoniazid-,er sanitary jurisdiction (January 2006 to March 2010)
Incidence rates and isolates analyzed*
nts/km2 Cases (%)† Incidence rate‡ MTC isolates (%)§
.6 352 (26.3) 7.9 39 (16.5)
9 28 (2.1) 3.0 8 (3.4)
.4 28 (2.1) 2.4 3 (1.3)
.3 122 (9.1) 12.0 39 (16.5)
.9 329 (24.6) 20.8 53 (22.4)
.6 480 (35.8) 33.4 95 (40.1)
.2 1339 (100.0) 12.6 237 (100.0)
Figure 1 Flow diagram indicating the PTB cases, the cultured,
recovered and spoligotyped MTC isolates, and the statistical,
geographic and genotypic analyses performed for this study.
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validate each assay, resistant cultures were compared
with drug-free controls.
Spoligotyping
From 432 MTC strains isolated at the Public Health State
Laboratory, 237 (54.9%) were sampled by convenience
(Figure 1): 39 from jurisdiction I, eight from jurisdiction
II, three from jurisdiction III, 39 from jurisdiction IV, 53
from jurisdiction V and 95 from jurisdiction VI. Sample
size was approximately proportional to the number of
PTB cases recorded in each jurisdiction (Table 1). The
MTC isolates selected were those maintained by subcul-
ture that yielded enough DNA for genotyping.
MTC DNA was extracted with the cetyl trimethylam-
monium bromide (CTAB) method [21]. Spoligotyping was
carried out according to the manufacturer’s instructions
with the Isogen kit which includes a nitrocellulose
membrane with 43 immobilized spacer sequences of the
direct repeat (DR) region (Life Science, Maarssen,
Netherlands). The spacers were amplified using primers
DRa (5′-GGTTTTGGGTCTGACGAC-3′) and DRb (5′-
CCGAGAGGGGACGGAAAC-3′) [8]. M. tuberculosis
H37Rv and CDC1551 and M. bovis BCG DNAs were
used as positive controls. Hybridization of the PCR
products was detected with the Direct Nucleic Acid
Labelling and Detection System (Amersham International
plc, Buckinghamshire, United Kingdom). Spoligotypes
were identified with the online MIRU-VTRNplus appli-
cation [22]. MTC lineages and families were assigned
after identifying the best matches among genotypes
from the internal reference database with a categorical
coefficient of 1.7. For additional tree-based identification,
a dendrogram of spoligotype patterns was generated using
the un-weighted pair group method with the neighbor-
joining algorithm. Spoligotype patterns were also com-
pared with those in the SITVIT2 database (Institut Pasteur
de Guadeloupe, http://www.pasteur-guadeloupe.fr:8081/SITVITDemo/) [23] and the Mbovis.org database
(Veterinary Laboratories Agency, http://www.mbovis.
org/index.php).
Statistical analysis and geographic distribution of MTC
species, lineages and families
Statistical analysis was carried out with the SPSS 18 soft-
ware (IBM Corporation, Somers, NY). The Pearson χ2 test
was used to assess differences in sociodemographic and
clinical variables among geographic zones, lineages and
drug resistance. Differences in the ages of cases among
geographic zones were assessed by one-way ANOVA.
P values ≤ 0.05 were considered statistically significant.
PTB cases and MTC lineages and families were linked to
geographical coordinates provided by the Instituto Nacional
de Estadística Geografía e Informática at city and commu-
nity scale [24]. MTC species, lineages and families were
mapped using ArcMap 9.2 software (Esri, Redlands, CA).
Results
Pulmonary TB incidence per sanitary jurisdiction and
region
From January 2006 to March 2010 the PTB incidence rate
for the state of San Luis Potosí was 12.6, with remarkable
differences per jurisdiction.
Jurisdictions I, II and III had lower incidence rates (7.9,
3.0, and 2.4, respectively); jurisdictions IV and V had inter-
mediate rates (12.0 and 20.8, respectively), and jurisdiction
VI, located in the southeastern end of the state, had the
maximum rate (33.4). The combined incidence rate of the
three jurisdictions with higher rates (IV, V and VI) was al-
most four times above that of jurisdictions with the lower
rates (I, II and III) (Figure 2A).
In view of these differences we divided the state in
three regions: the low incidence region (jurisdictions I, II
and III with a combined rate of 6.2); the intermediate
region (jurisdictions IV and V with a combined rate of
17.3); and the high incidence region (jurisdiction VI,
with a rate of 33.4) (Figure 2B, Table 2).
In the high incidence region the median age of con-
firmed PTB cases (55 years) was ten years higher and sig-
nificantly different (P = 0.031) to that of the low incidence
region, and seven years higher than that of the intermedi-
ate incidence region. The proportion of patients living in
rural communities increased significantly (P < 0.001) from
the low (17.5%) to the intermediate (54.2%) and high inci-
dence (86.3%) regions. The proportion of patients residing
in municipalities of high marginalization also increased
significantly (P < 0.001) from the low (19.0%) to the inter-
mediate (21.7%) and high incidence (100.0%) regions.
Features of the PTB cases
The overall median age of PTB cases in the state was
50 years. Two thirds (62.5%) were men, one half (50.4%)
Figure 2 PTB incidence rates by jurisdiction and region. (A) Incidence rate by sanitary jurisdiction. Roman numerals followed by Arabic
numerals indicate each one of the six sanitary jurisdictions of the state of San Luis Potosí and their corresponding PTB incidence rates (per
100,000 inhabitants) in 2008. (B) Regions of low (jurisdictions I, II and III), intermediate (jurisdictions IV and V), and high (Jurisdiction VI) incidence,
with their corresponding rates.
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or farm workers, and one third (31.0%) were housewives.
Nearly two thirds (61.7%) had either incomplete primary
education or no formal education at all. More than half
(58.1%) resided in rural localities and 53.2% in highly
marginalized municipalities (Table 2).
Most cases (90.3%) did not have a previous history of
TB and 75.0% declared not to have contacted other PTB
cases. One half (51.2%) had a concomitant disease; the
most frequent was diabetes (21.4%), followed by malnu-
trition (16.5%) and alcoholism (9.3%).
Diabetes-PTB association decreased significantly (P = 0.047)
from the low (31.7%) to the intermediate (22.9%) and high
incidence (13.7%) regions. In contrast, malnutrition-PTB
association did not increase significantly (P = 0.061) from
the high incidence region (6.3%) to the intermediate
(18.1%) and low incidence (21.6%) regions. Alcoholism as
a concomitant disease increased significantly (P = 0.026)
from the low incidence region (1.6%) to the intermediate
(8.4%) and high incidence (14.7%) regions. Marginalization
is directly related to malnutrition and alcoholism and in-
versely related to diabetes since the first two concomitant
diseases predominate in the high incidence region and
diabetes in the low incidence region.
Lineages, families and clusters of the MTC isolates
Spoligotypes of the 237 isolates analyzed corresponded
to two MTC species: 232 to M. tuberculosis (97.8%) and
five to M. bovis (2.1%). Four lineages and 109 genotypes
were identified (Figure 3). Fifty five genotypes (50.5%)
had already been registered (53 in SpolDB4 and three in
the Mbovis.org database; one of the five M. bovis geno-
types had been registered in both databases).
Of the M. tuberculosis isolates, 221 (95.3%) had Euro-
American lineage spoligotypes, among which 118 (53.4%)
were SIT53, SIT42, SIT20, SIT221, SIT239, SIT50,SIT787, SIT17 and SIT258, and 55 isolates (24.9%) had
previously undetected (“orphan”) Euro-American geno-
types. Eleven isolates had spoligotypes characteristic of
other lineages and families: eight (3.4%) corresponded to
the EAI-Manila family of the Indo-Oceanic lineage, and
three isolates with identical spoligotypes (1.3%) to the
Beijing family of the East-Asian lineage. Of the 109 geno-
types identified, 85 (78.0%) appeared in a single isolate
and the remaining 24 (22.0%) in clusters of two up to 68
isolates (Table 3).
One hundred and fifty two isolates (64.1%) were grouped
in clusters. The two largest clusters were formed by 68
isolates of SIT53 genotype and 14 isolates of SIT42 geno-
type (Table 3).
Euro-American isolates were distributed all over the
state (Figure 4A). Beijing isolates were located in the San
Luis Potosí City metropolitan area (Figure 4B), EAI-
Manila isolates in the easternmost jurisdictions V and
VI, and M. bovis isolates in five southern rural commu-
nities from jurisdictions I, IV and V (Figure 4B).
Thus in the state of San Luis Potosí there is great genetic
diversity in the circulating MTC strains, among which the
Euro-American lineage predominates.Lineages and families of drug-resistant MTC isolates
Twenty-three of the 237 spoligotyped isolates were resist-
ant to one or more drugs: nine were resistant to isoniazid,
two to rifampicin, two to other drugs, and 10 were MDR
(Table 4).
Eleven of the 13 single-drug-resistant isolates were of
the Euro-American lineage. Among the MDR isolates,
nine were of the Euro-American lineage and one was of
the Indo-Oceanic (EAI-Manila) lineage. One rifampicin-
resistant isolate was of the EAI-Manila family and one
isoniazid-resistant isolate was of the Beijing family.
Table 2 Sociodemographic and clinical variables of the PTB cases in the low-, intermediate- and high-incidence regions
of the state
Variable Incidence region* P†
Low (6.2) Intermediate (17.3) High (33.4) Overall (12.6)
Number of PTB cases 63 83 102 248 —
Sex
Male 40 (63.5) ‡ 47 (56.6) 68 (66.7) 155 (62.5) 0.670
Female 23 (36.5) 36 (43.4) 34 (33.3) 93 (37.5) 0.861
Median age
Years (range) 45 (18–86) 48 (15–80) 55 (16–95) 50 (15–95) 0.031
Occupation
Farm worker 15 (23.8) 25 (30.1) 43 (42.2) 83 (33.5) 0.116
Housewife 18 (28.6) 31 (37.3) 28 (27.5) 77 (31.0) 0.449
Unemployed 11 (17.5) 12 (14.5) 19 (18.6) 42 (16.9) 0.779
Employee 12 (19.0) 4 (4.8) 3 (2.9) 19 (7.7) 0.001
Independent 5 (7.9) 8 (9.6) 7 (6.9) 20 (8.1) 0.819
Another 2 (3.2) 3 (3.6) 2 (2.0) 7 (2.8) 0.779
Formal education
None 13 (20.6) 21 (25.3) 36 (35.3) 70 (28.2) 0.522
Incomplete primary 21 (33.3) 29 (34.9) 33 (32.4) 83 (33.5) 0.638
Primary 16 (25.4) 21 (25.3) 20 (19.6) 57 (23.0) 0.951
Secondary 11 (17.5) 12 (14.5) 11 (10.8) 34 (13.7) 0.192
College 2 (3.2) 0 (0) 2 (2.0) 4 (1.6) 0.301
Habitat
Rural 11 (17.5) 45 (54.2) 88 (86.3) 144 (58.1) < 0.001
Urban 52 (82.5) 38 (45.8) 14 (13.7) 104 (41.9) < 0.001
Marginalization index
Very high 0 (0) 9 (10.8) 0 (0) 9 (3.6) < 0.001
High 12 (19) 18 (21.7) 102 (100.0) 132 (53.2) < 0.001
Medium 2 (3.2) 33 (39.8) 0 (0) 35 (14.1) < 0.001
Low 1 (1.6) 23 (27.7) 0 (0) 24 (9.7) < 0.001
Very low 48 (76.2) 0 (0) 0 (0) 48 (19.4) < 0.001
Previous history of TB
No 59 (93.7) 75 (90.4) 90 (88.2) 224 (90.3) 0.951
Yes 4 (6.3) 8 (9.6) 12 (11.8) 24 (9.7) 0.549
Contact with TB cases
Yes 8 (12.7) 24 (28.9) 29 (28.4) 61 (24.6) 0.086
No 55 (87.3) 59 (71.1) 73 (28.4) 187 (75.4) 0.449
Concomitant disease
None 34 (54.0) 37 (44.6) 50 (49.0) 121 (48.8) 0.741
Diabetes 20 (31.7) 19 (22.9) 14 (13.7) 53 (21.4) 0.047
Malnutrition 4 (6.3) 15 (18.1) 22 (21.6) 41 (16.5) 0.061
Alcoholism 1 (1.6) 7 (8.4) 15 (14.7) 23 (9.3) 0.026
HIV-AIDS 4 (6.3) 1 (1.2) 0 (0) 5 (2.0) 0.017
Other 0 (0) 4 (4.8) 1 (1.0) 5 (2.0) 0.082
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Table 2 Sociodemographic and clinical variables of the PTB cases in the low-, intermediate- and high-incidence regions
of the state (Continued)
Acid-fast bacilli smear
Positive 56 (88.9) 78 (94.0) 100 (98.0) 234 (94.4) 0.016
Negative 7 (11.1) 5 (6.0) 2 (2.0) 14 (5.6) 0.584
*Number of cases per 100,000 inhabitants in parenthesis.
†χ2. One-way ANOVA, for age difference.
‡Numbers in parenthesis are percentages between variable categories, except in the median age where they are ranges.
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came from jurisdictions V and VI.
In summary, 9.7% of the isolates were resistant to one
or more drugs and 4.2% were MDR; 3.8% were resistant
only to isoniazid, 0.8% only to rifampicin and 0.8% to
other drugs. Although most (84.6%) of the single drug-
resistant isolates and 90% of the MDR ones were of the
Euro-American lineage, association between drug resist-
ance of any kind with the lineage or family of the isolates
was not significant (P = 0.653).Discussion
Low socioeconomic status, a TB determinant, includes
risk factors such as food insecurity, poor housing and
cultural, financial and geographic barriers for access to
health services [25]. We confirmed that in San Luis
Potosí PTB incidence correlates with low socioeconomic
status since nearly two thirds of the patients resided in
rural communities and more than half of them lived in
highly marginalized municipalities.
Overall PTB incidence in the state (12.6) is remarkably
different to that of each sanitary jurisdiction and led us
to divide the state in three incidence regions (Figure 2).
The low incidence region comprises jurisdictions I, II
and III; the intermediate incidence region comprises ju-
risdictions IV and V. The high incidence region corre-
sponds to jurisdiction VI; located in the southeastern
part of the state, it is a tropical, predominantly rural and
highly marginalized area, with 48% of indigenous popu-
lation [21] and a population density 1.5 higher than that
of the other jurisdictions combined, except for jurisdic-
tion I, where the capital city is located [16].
Marginalization indexes differentiate municipalities by
the impact of variables threatening life quality such as
house overcrowding, low educational level and lack of
electricity, running water and sanitary services [20]. In
San Luis Potosí we confirmed that regional TB incidence
correlates with the socioeconomic gradient, as is known
to occur within countries and within communities, the
poorest ones being affected most [26].
Although residents of urban areas are believed to be at
higher risk of TB [25], most of the cases in the high inci-
dence region reside in rural communities. This finding
may be due to risk factors such as overcrowding, indoorpollution, and poor ventilation in the rural communities
affected. Marginalization is directly related to the inci-
dence of malnutrition and alcoholism and inversely re-
lated to the incidence of diabetes since the first two
concomitant diseases predominate in the high incidence
region and diabetes in the low incidence region.
Sociodemographic and clinical variables in the low in-
cidence region are similar to those in Monterrey and
Acapulco [11,12], two Mexican cities of relatively low
marginalization. In contrast, such variables in the high
incidence region resemble more those of highly marginal
rural regions of the Mexican state of Chiapas [27] where
the average age of PTB cases is around 40 years, whereas
in the high incidence region of San Luis Potosí it is close
to 53 years. Both the transmission-mutation index derived
from the spoligoforest analysis and the transmission
chains identified by MIRU-VNTR genotyping indicate that
recent transmission contributes marginally to the epidemi-
ology of TB (E. López-Rocha et al., manuscript in prepar-
ation), whereas the advanced age of the cases and the high
proportion of positive acid-fast bacilli smears (94.4%) indi-
cates delayed disease detection. These findings support
the notion that in San Luis Potosí endogenous reactivation
contributes to TB epidemiology much more than recent
transmission [28].
One tenth of the MTC isolates in San Luis Potosí are re-
sistant to one or more drugs; 4.2% are MDR, a proportion
below the national average of 5.8% [29] and lower than
that of the American continent (7.2%) [3]. No statistically
significant association of drug resistance and MTC lineage
was found.
Most of the spoligotyped MTC isolates corresponded to
M. tuberculosis and only 2.1% to M. bovis. M. tuberculosis
isolates had 104 different genotypes among which only 52
(50.0%) had been registered in SpolDB4, and correspond
to three lineages: Euro-American, Indo-Oceanic and East-
Asian. A comprehensive study of MTC genotypes based
on the analysis of large sequence polymorphisms found
that Euro-American is the predominant M. tuberculosis
lineage in Latin America [30]. The same lineage has been
shown to be prevalent in the Mexican cities of Orizaba [5]
and Monterrey [11], and we also found it to be the most
prevalent in San Luis Potosí (95.3%) with SIT53, SIT42,
SIT20, SIT221, SIT239, SIT50, SIT787, SIT17 and SIT258
as its main genotypes.
Figure 3 (See legend on next page.)
López-Rocha et al. BMC Research Notes 2013, 6:172 Page 7 of 11
http://www.biomedcentral.com/1756-0500/6/172
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Figure 3 Dendrogram, families and spoligotype patterns of the 109 MTC genotypes identified. M. tuberculosis isolates of the Euro-
American lineage are indicated with smaller font labels and those of other lineages and M. bovis isolates are indicated with larger font labels and
their spoligotype patterns enclosed in rectangles. SIT: Spoligo international type numbers from the SpolDB4 database. M. bovis spoligotype
identifiers (marked with asterisks) from the Mbovis.org database.
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types are grouped in clusters, the largest one being that
with 68 isolates of the SIT53 genotype, and the second
largest with 14 isolates of the SIT42 genotype. The SIT53
genotype, belonging to the ill-defined T1 sublineage, is
ubiquitous and the most frequent in SpolDB4 [23]; the
SIT42 genotype is also ubiquitous and ranks sixth in the
same database. In the Mexican city of Monterrey the lar-
gest cluster corresponds to the SIT53.
The least frequent M. tuberculosis lineages in San Luis
Potosí are the Indo-Oceanic (EAI-Manila family, 3.4%)
and the East-Asian (Beijing family, 1.3%). The EAI-Manila
family —endemic in Southeast Asia, South India and East
Africa— was recognized in Filipino immigrants in the
United States and later shown to be highly prevalent inTable 3 Spoligotype patterns and octal codes of the 24 MTC
Cluster ID SIT* N†
c-24 53 68 1111111111
c-18 42 14 1111111111
c-10 20 7 1101111111
c-16 221 7 1111111111
c-21 239 6 1111111111
c-20 50 5 1111111111
c-22 787 5 1111111111
c-9 19 4 1101111111
c-12 2111 3 1110000011
c-1 1 3 0000000000
c-4 258 3 0000000000
c-8 17 3 1101111111
c-11 — 2 1101111111
c-13 33 2 1111111100
c-14 37 2 1111111111
c-15 — 2 1111111111
c-17 1277 2 1111111111
c-19 2070 2 1111111111
c-23 52 2 1111111111
c-2 2 2 0000000000
c-3 125 2 0000000000
c-6 — 2 1100011111
c-7 194 2 1101111111
c-5 — 2 1011011011
*SIT, Spoligo international type number in SpolDB4.
†Number of isolates sharing the same spoligotype.the Philippines [31]. It was identified in Mexico for the
first time in Orizaba, Veracruz [32]. Four of our eight
EAI isolates correspond to the ubiquitous and common
SIT19 genotype and could also have originated from the
Philippines, given the commercial links of that region with
Mexico from 1565 to 1815 through the Manila-Acapulco
galleon [33]. This hypothesis is consistent with the recent
finding that one fourth of the M. tuberculosis isolates in
Acapulco correspond to the EAI family [12], where the
largest cluster has the SIT19 genotype previously found in
Monterrey [11], and now by us in a cluster with four
isolates.
Our three Beijing isolates have the SIT1 genotype and,
although a transmission chain cannot be discarded, their
low prevalence suggests they arose from independentclusters found

























Figure 4 Geographic distribution of the Euro-American and other MTC lineages found. (A) Distribution of the Euro-American lineage.
(B) Distribution of the EAI, Beijing and Bovis lineages. The symbols indicate the localities with PTB cases associated to each lineage; the area of
each circle is proportional to the number of cases per locality.
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http://www.biomedcentral.com/1756-0500/6/172transmission events. SIT1, the second most frequent
genotype in SpolDB4 [23], is ubiquitous —it has been
identified in 29 countries and eight geographic areas—,
epidemic (propagation index = 44.2), highly virulent [34]
and appears to have selective advantages over other
genotypes [35]. Only one Mexican PTB case by a Beijing
strain from Orizaba, Veracruz, has been published [5].
Although the presence of this genotype in San Luis
Potosí is worrying, its low frequency suggests that up to
now its transmission is negligible.
The genetic diversity of the MTC appears to be geo-
graphically structured [30], since some strains preferably
infect certain human populations and the association
between pathogens and their hosts appear to be stable
[36]. These data led to the notion that the worldwide TB
pandemic is the sum of genetically different outbreaks
[23]. Since the Euro-American lineage is distributed all
over the state, the Beijing family is limited to the capital
metropolitan area and the EAI-Manila family to the east-
ern part of the state, the TB epidemic in San Luis Potosí
may be interpreted as a part of the wider TB epidemic
in Latin America, with an outbreak of the EAI lineage
and some Beijing cases.
All our five M. bovis isolates have different spoligotypes
and come from rural communities located in the dairy
region of the state. The prevalence of human TB of
bovine origin in San Luis Potosí may be much higherTable 4 Lineages of the drug-resistant MTC isolates
Lineage Single-drug resistan
Isoniazid Rifampicin
Euro-American 8 (3.4%) 1 (0.4%)
Indo-Oceanic (EAI) 0 1 (0.4%)
East-Asian (Beijing) 1 (0.4%) 0
Total 9 (3.8) 2 (0.8%)
*Isolates resistant to one first line drug other than isoniazid or rifampicin.than 2.1% since bovine TB has been eradicated from
only one Mexican state [37], and all the MTC isolates
recovered for this study were initially cultured in
Lowenstein-Jensen medium, more appropriate for M.
tuberculosis than for M. bovis [38]. Therefore, the sur-
veillance of human TB caused by M. bovis must be
reinforced in the state health program.
The MTC strains included in this study were only
those that were kept and recovered at the Public Health
State Laboratory, where most state TB cases are concen-
trated. Although scarce, cases from individuals affiliated
to the Mexican Social Security Institute or other organi-
zations may have been overlooked. On the other hand,
minor mistakes in the assignment of MTC lineages and
families may have occurred, since the dendrogram-based
similarities used by us to identify the isolates are known
to be 94.1% accurate [39].
The prevalence of human TB due to M. bovis corre-
lates with TB prevalence in cattle, and most human
cases are related to consumption or handling of contam-
inated dairy products [40]. Although the prevalence of
human TB of bovine origin in Mexico is unknown, 5.3%
of the MTC strains isolated from sputum samples of PTB
cases in a zone endemic for bovine TB in the Mexican
state of Querétaro had M. bovis spoligotypes [13]. In the
same endemic zone a study on asymptomatic farm
workers identified M. bovis spoligotypes in 10.8% ofce MDR Total
Other drugs*
2 (0.8%) 9 (3.8%) 20 (8.4%)
0 1 (0.4%) 2 (0.8%)
0 0 1 (0.4%)
2 (0.8%) 10 (4.2%) 23 (9.7%)
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http://www.biomedcentral.com/1756-0500/6/172sputum and 5.3% of urine samples [14]. Other popula-
tion studies in Mexico found M. bovis spoligotype fre-
quencies of 0.6% in Monterrey [11] and 0.4% in
Acapulco [12].
Conclusions
This is the first study on the molecular epidemiology of
TB which covers a complete state in Mexico. In the state
of San Luis Potosí, PTB incidence correlates with low
socioeconomic status and the prevalent MTC strains
show high genetic diversity and appear to be part of the
wider TB epidemic in Latin America. Our findings show
the need to implement TB control plans adapted to each
incidence region in the state, including routine monitor-
ing of the circulating MTC genotypes and reinforcing
M. bovis surveillance.
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